Home » Building BRICs: Pharma’s Key Emerging Markets Are Becoming Giants
Building BRICs: Pharma’s Key Emerging Markets Are Becoming Giants
The BRIC nations — Brazil, India, Russia and China — should no longer be classified as developing pharmaceutical markets, as their markets are not very different in size from the traditional “Western” pharmaceutical markets.
PMLive
PMLive
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May